Exploring the Anticancer and Immunomodulatory Mechanisms of Phytochemicals and Natural Bioactive Compounds

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".

Deadline for manuscript submissions: 15 January 2025 | Viewed by 10

Special Issue Editor


E-Mail Website
Guest Editor
College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea
Interests: Natural products; anticancer; immunomodulation

Special Issue Information

Dear Colleagues,

Natural products have long been valuable for drug discovery and development, especially in oncology and immunology. This Special Issue focuses on the anticancer and immunomodulatory mechanisms of phytochemicals and other bioactive compounds derived from natural sources. Recent advancements have highlighted the potential of these compounds to modulate various cellular pathways, enhance immune responses, and inhibit cancer cell proliferation and metastasis.

Phytochemicals exhibit diverse mechanisms of action, including the induction of apoptosis, cell cycle arrest, and inhibition of angiogenesis. These natural compounds often target multiple signaling pathways, making them effective against various cancer types and reducing the likelihood of drug resistance. Furthermore, many natural products possess immunomodulatory properties, enhancing the body’s immune system to recognize and eliminate cancer cells. They can stimulate the activity of immune cells, such as T cells and natural killer cells, and modulate the production of cytokines and other immune mediators.

This issue invites submissions that explore the molecular mechanisms, bioavailability, and therapeutic potential of natural compounds in cancer treatment and immune regulation. Studies on novel natural products, combination therapies, and clinical trials are welcome. By understanding and harnessing the power of natural compounds, we can develop more effective and less toxic therapies for cancer and immune-related diseases.

Prof. Dr. Suyun Lyu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • phytochemicals
  • anticancer
  • immunomodulation
  • bioactive compounds

Published Papers

This special issue is now open for submission.
Back to TopTop